dMed Biopharmaceutical Co., Ltd. dba Caidya

dMed is Now Caidya! Caidya is a global, multi-therapeutic clinical research organization (CRO) dedicated to advancing healthcare innovation and accelerating the development of new therapies. With full-service capabilities and a strategic footprint in 23 countries and regions, our global network provides broad access to diverse patient populations across the Americas, Europe, and APAC. Caidya’s in-depth therapeutic and operational expertise helps partners conduct studies with greater efficiency and confidence. Our commitment to excellence and data-driven decision-making ensures the highest quality standards across all phases of the drug development process. Caidya provides comprehensive clinical trial services from regulatory strategy and submissions, clinical operations, biometrics, and quality management, through post-approval surveillance. Following the merger of dMed and Clinipace, Caidya launched with a clear purpose to liberate clinical research and bring life-changing therapies to our global community.

网站

https://www.caidya.com

dMed Biopharmaceutical Co., Ltd. dba Caidya的外部链接

所属行业

制药业

规模

1,001-5,000 人

总部

Morrisville，NC

类型

私人持股

创立

2016

领域

Strategic Consultation、Clinical Operations、Biostatistics & Programming、Clinical Sciences & Medical Affairs、Drug Safety & Pharmacovigilance、Regulatory Affairs & Strategy 、Quality Assurance and Audit、Data Management和Training